With Henry Schein (NASDAQ: HSIC) set to report its second-quarter earnings results on August 7, 2023, at 10:00 AM EST, investors and stakeholders are eagerly anticipating the release. As a leading provider of healthcare products and services to dental practitioners and medical professionals, Henry Schein has established itself as a key player in the industry. In this article, we will analyze the upcoming earnings call from multiple perspectives – fundamental, technical, historical guidance, and analysts’ estimates – to provide readers with valuable insights into the company’s financial health and performance.
Taking a closer look at Henry Schein‘s past year financials, the company has consistently demonstrated stability and growth. In the second quarter of 2023, the company reported a net income of $140 million and total revenue of $3.1 billion. With a diluted EPS of $1.06 million, Henry Schein has surpassed market expectations, setting a solid foundation for the upcoming earnings call.
Furthermore, the sequential growth in net income and total revenue over the past four quarters is a testament to Henry Schein‘s business resilience and ability to adapt to changing market dynamics. Both the net income and total revenue have been steadily increasing, reflecting the company’s robust performance in a highly competitive healthcare market.
Analyzing Henry Schein‘s past three-month price performance, it is evident that the stock has been relatively stable with minor fluctuations. The stock price ranged from a low of $72.9 to a high of $82.6 during this period. While the recent one-day change recorded a slight decline of 0.2%, it is essential to note that overall sentiment remains positive.
Investors should also monitor the moving averages and support/resistance levels to gauge potential price movements. The stock’s long-term moving averages indicate stability, suggesting that Henry Schein has a solid foundation to support its growth trajectory. Additionally, the positive sentiment in recent news surrounding the upcoming earnings call further strengthens the stock’s technical outlook.
Henry Schein‘s historical performance is crucial in providing insight into its future prospects. Looking at the quarterly diluted EPS for the past year, the consensus estimate has remained consistent at $1.28. This consistency highlights the company’s ability to meet or exceed market expectations consistently.
The steady growth of diluted EPS over the past year showcases Henry Schein‘s resilience and ability to generate profits despite prevailing challenges. This track record provides investors and analysts with confidence in the company’s ability to deliver consistent earnings growth.
Analysts have closely monitored Henry Schein‘s performance leading up to the upcoming earnings call. Based on Morningstar consensus estimates, analysts forecast an adjusted EPS of $1.28 for the second quarter. This aligns with the estimates from 30, 60, and 90 days ago, indicating a consensus opinion on the company’s stability and growth potential.
With analysts maintaining their estimates throughout, the market is likely anticipating a solid earnings report from Henry Schein. Shareholders can take comfort in the stability of the company’s earnings forecast, which suggests that consistent results can be expected.
As Henry Schein prepares to release its second-quarter earnings results, investors and stakeholders have reason to be optimistic about the company’s financial performance. The fundamental analysis showcases solid financials, including consistently growing net income and total revenue. Technical analysis reveals overall stability and positive sentiment in recent news coverage. Historical guidance exemplifies the company’s ability to meet or exceed market expectations consistently. Lastly, analysts’ estimates support the positive sentiment surrounding Henry Schein, with a consensus expectation of an adjusted EPS of $1.28.
Investors and stakeholders are encouraged to tune in to Henry Schein‘s upcoming earnings call to gain further insights into the company’s performance and growth prospects. With a strong foundation, stable stock performance, and positive market sentiment, Henry Schein is well-positioned for continued success in the healthcare industry.
Disclaimer: The information provided in this article is based solely on the data and numbers provided. Investors are advised to conduct their own research and consult with a financial advisor before making any investment decisions.